Computerized Single-Session Interventions for Indian Adolescents

June 25, 2020 updated by: Akash Wasil, University of Pennsylvania

Evaluating the Acceptability and Efficacy of Computerized Single-Session Interventions for Indian Adolescents

The overall aim of this project is to understand if single-session interventions are acceptable, culturally appropriate, and effective for Indian adolescents. The investigators will be examining the effects of three interventions on the well-being and mental health of adolescents. The investigators hypothesize that at least one of the three interventions will yield statistically significant improvements in wellbeing and mental health relative to a study skills control condition.

Study Overview

Study Type

Interventional

Enrollment (Actual)

958

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pune, India
        • Modern College Pune
    • Maharashtra
      • Pune, Maharashtra, India
        • Dr. Kalmadi Junior High School
      • Pune, Maharashtra, India
        • The Orchid School
      • Roha, Maharashtra, India
        • JM Rathi English School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Attending a participating secondary school
  • Age 12 to 18
  • Literate in English

Exclusion Criteria:

  • Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Activation
Reading and writing activities designed to identify and schedule positive activities.
Experimental: Growth Mindset
Reading and writing activities designed to instill the belief that people can change.
Experimental: Gratitude
Reading and writing activities designed to practice noticing and appreciating good things in life.
Sham Comparator: Study Skills
Reading and writing activities designed to learn evidence-based study strategies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in The Warwick-Edinburgh Mental Wellbeing Scale
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
Well-being questionnaire. Total score ranges from 14 to 70. Higher values indicate a better outcome.
Baseline, 4 week follow-up, 12 week follow-up
Intervention Appropriateness Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
Questionnaire measuring the appropriateness of an intervention. Appropriateness refers to the perceived fit or relevance of an intervention. The total score ranges from 4 to 20. Higher scores indicate a better outcome.
Immediately post-intervention (i.e., 0 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire-9
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
Depression Questionnaire. The total score ranges from 0 to 27. Lower scores indicate a better outcome.
Baseline, 4 week follow-up, 12 week follow-up
The EPOCH Measure of Adolescent Well-being
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
Questionnaire with five subscales measuring engagement, perseverance, optimism, connectedness, and happiness. Each subscale score ranges from 4 to 20. Higher scores indicate a better outcome. The happiness and optimism subscales will be used as secondary outcomes for this trial. A total score is not computed.
Baseline, 4 week follow-up, 12 week follow-up
Acceptability of Intervention Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate a better outcome.
Immediately post-intervention (i.e., 0 weeks)
Feasibility of Intervention Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
Questionnaire measuring the feasibility of an intervention. Feasibility refers to the degree to which a treatment can be successfully implemented in a given setting. The total score ranges from 4 to 20. Higher scores indicate a better outcome.
Immediately post-intervention (i.e., 0 weeks)
Generalized Anxiety Disorder Screener-7
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome.
Baseline, 4 week follow-up, 12 week follow-up
Perceived Stress Scale-4
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
Questionnaire measuring perceived stress. The total score ranges from 0 to 16. Lower scores indicate a better outcome.
Baseline, 4 week follow-up, 12 week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Rob DeRubeis, PhD, University of Pennsylvania
  • Study Director: Sachin Shinde, PhD, Sangath
  • Study Director: Sadhana Natu, PhD, Modern College Pune

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2019

Primary Completion (Actual)

March 15, 2020

Study Completion (Actual)

June 4, 2020

Study Registration Dates

First Submitted

June 5, 2019

First Submitted That Met QC Criteria

June 7, 2019

First Posted (Actual)

June 11, 2019

Study Record Updates

Last Update Posted (Actual)

June 29, 2020

Last Update Submitted That Met QC Criteria

June 25, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24922

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Growth Mindset

3
Subscribe